Department of Pharmacology, Institute of Pharmaceutical Technology, Sri Padmavati Mahila Visvavidyalayam (Women's University), Tirupati, Andhra Pradesh, India.
Indian J Pharmacol. 2021 Mar-Apr;53(2):132-142. doi: 10.4103/ijp.IJP_837_19.
Water contaminated with arsenic affected millions of people worldwide and arsenic exposure is related to various neurological disorders. Hence, the current study was planned to investigate the neuroprotective activity of diosmin (DSN) against arsenic induced neurotoxicity as an attempt to identify therapeutic intervention to combat arsenicism.
Sodium arsenite an inducer of neurotoxicity was administered orally (13 mg/kg) and DSN treatment at two selected doses (50 and 100 mg/kg) was done for 21 days. Behavioral and biochemical variations were examined by various parameters. Furthermore, histopathological and immunohistochemistry studies were done with the brain sections.
The behavioral studies evidenced that arsenic has suppressed the exploratory behavior and motor coordination in rats and DSN treatment has recovered the behavioral changes to normal. Arsenic administration has also found to induce oxidative stress and DSN co-treatment has ameliorated the oxidative stress markers. Interestingly, depleted levels of neurotransmitters were observed with the arsenic and it was restored back by the DSN treatment. Histopathological alterations like pyknosis of the neuronal cells were identified with arsenic exposure and subsided upon DSN co administration. Immunohistochemical studies have revealed the expression of NOX4 and its gp91 and P47 subunits and its suppression by DSN treatment may be the key therapeutic factor of it.
Treatment with DSN showed a beneficial effect in protecting against arsenic-induced neurotoxicity by suppressing the toxicity changes and the antioxidant effect of DSN might be attributed to its ability of suppressing NOX4 and its subunits.
受砷污染的水影响了全球数百万人,并且砷暴露与各种神经紊乱有关。因此,本研究旨在研究地奥司明(DSN)对砷诱导的神经毒性的神经保护活性,试图确定治疗干预砷中毒的方法。
亚砷酸钠(一种神经毒性诱导剂)经口给予(13mg/kg),并以两种选定剂量(50 和 100mg/kg)给予 DSN 治疗 21 天。通过各种参数检查行为和生化变化。此外,还对脑切片进行了组织病理学和免疫组织化学研究。
行为研究表明,砷抑制了大鼠的探索行为和运动协调能力,而 DSN 治疗使行为变化恢复正常。砷给药还发现会引起氧化应激,而 DSN 联合治疗可改善氧化应激标志物。有趣的是,观察到与砷一起存在的神经递质水平下降,而 DSN 治疗使其恢复正常。组织病理学改变,如神经元细胞的固缩,在砷暴露时被识别出来,并在 DSN 联合给药时减轻。免疫组织化学研究揭示了 NOX4 及其 gp91 和 P47 亚基的表达,DSN 治疗对其的抑制可能是其关键治疗因素。
DSN 治疗可通过抑制毒性变化和 DSN 的抗氧化作用,对砷诱导的神经毒性产生有益的保护作用,DSN 的抗氧化作用可能归因于其抑制 NOX4 及其亚基的能力。